Phase 4 N=449 Understanding Disparities in Quitting in African American and White Smokers
Smoking Cessation
Primary: Number of Participants With Cotinine-verified 7-day Point Prevalence Smoking Abstinence at Week 26 — 32; 55 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=47 Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury
Acute Liver Failure · Acute Liver Injury
Primary: Number of Participants That do Not Tolerate the Administered Dose and Had Grade 3 or 4 Treatment Emergent Adverse Events as a Measure of Safety and Tolerability — 0; 0…
N/A N=21 Effect of Olopatadine on Allergic Tear Mediators
Allergic Conjunctivitis
Primary: Study Examined Whether the Incubation of Human Conjunctival Epithelial Cells With Tears Pooled From Allergic Subjects (One Eye With and Other Eye Without Olopatadine…
N/A N=60 Study to Compare the Effect of Two Different Types of Humidifier on the Endotracheal Tube Patency
Cancer of Head and Neck
Primary: Extent of Blockade of Endotracheal Tube Assessed by Change in the Endotracheal Tube Volume — 8.81; 14.08 percentage change of ET tube volume
Phase 2 N=17 A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Leukemia, Myeloid
Primary: Number of Participants Who Achieved a Morphologic Complete Response Within the First Four Cycles of Lenalidomide Treatment According to the Modified International…
N/A N=67 Smart Television and Exercise Promotion for Independent Living Facilities
Aging · Physical Activity
Primary: System Usability Scale (SUS) — 73.57; 74.70 units on a scale
Phase 4 N=200 A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Primary: Difference in Multiple Sclerosis Treatment Concern Questionnaire (MSTCQ) Flu Like Symptom (FLS) Score Between Rebif Morning Administration and Rebif Evening…
N/A N=106 Targeting Caregivers to Enhance Health Behaviors in Pediatric Cancer Survivors
Obesity · Cancer
Primary: Satisfaction and Exit Survey Composite Scale Score -- ONLY CAREGIVERS COMPLETED THIS MEASURE — 46.2; 37.5 units on a scale — p=<.05
N/A N=62 Study of the Effect of the Drug Gabapentin on Postoperative Pain and Incidence of Postoperative Nausea and Vomiting
Obesity, Morbid · Postoperative Pain · Postoperative Nausea and Vomiting
Primary: Evaluate the Amount of Diluadid Given Postoperatively — 11.035; 8.7; 12.4 ml
Phase 4 N=26 Reduction of Bladder Injection Pain With Belladonna Opiate Suppository
Overactive Bladder · Urinary Urge Incontinence · Urinary Bladder, Neurogenic
Primary: Change in Bladder Injection Pain — 5; 4; 5 units on a scale — p=0.94
Phase 2 N=151 A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer
Breast Cancer
Primary: Percentage of Participants With Pathological Complete Response (pCR) in Breast and Axilla as Defined by ypT0/Tis ypN0 in the American Joint Committee on Cancer Staging…
N/A N=60 Caminamos: A Smartphone App to Connect With Walking Partners
Physical Activity
Primary: System Usability Questionnaire — 60.54; 63.32 units on a scale
Phase 1 N=40 BAX 826 Dose-Escalation Safety Study
Hemophilia A
Primary: Serious AEs (SAEs) and Non-serious AEs Occurring After Infusion With BAX 826 — 20; 12; 15; 0 Adverse Events
N/A N=508 PREDICT-SpA - French Epidemiological Study of the Evaluation of the Impact of Fibromyalgia in the TNF Alpha Treatment Effect in Axial Spondyloarthritis in Both Anti-TNF naïve and - Experienced Patients
Axial Spondyloarthritis · Fibromyalgia
Primary: To Evaluate the Presence of Fibromyalgia (Defined by a FIRST Questionnaire >= 5/6) as a Predisposing Factor for Lower Treatment Response Rates to TNF Alpha Blockers…
Phase 1 N=12 A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer
Pancreatic Cancer
Primary: Maximum Tolerated Dose — NA mg